These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 28144922)

  • 1. Current concepts and strategies in the diagnosis and management of idiopathic intracranial hypertension in adults.
    Chan JW
    J Neurol; 2017 Aug; 264(8):1622-1633. PubMed ID: 28144922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of idiopathic intracranial hypertension in parturients: anesthetic considerations.
    Karmaniolou I; Petropoulos G; Theodoraki K
    Can J Anaesth; 2011 Jul; 58(7):650. PubMed ID: 21519980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on Idiopathic Intracranial Hypertension.
    Kanagalingam S; Subramanian PS
    Curr Treat Options Neurol; 2018 May; 20(7):24. PubMed ID: 29808423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the complex pathophysiology of idiopathic intracranial hypertension and the evolving role of venous sinus stenting: a comprehensive review of the literature.
    Giridharan N; Patel SK; Ojugbeli A; Nouri A; Shirani P; Grossman AW; Cheng J; Zuccarello M; Prestigiacomo CJ
    Neurosurg Focus; 2018 Jul; 45(1):E10. PubMed ID: 29961379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fulminant Idiopathic Intracranial Hypertension.
    Bouffard MA
    Curr Neurol Neurosci Rep; 2020 Mar; 20(4):8. PubMed ID: 32219578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review of surgical treatments of idiopathic intracranial hypertension (IIH).
    Kalyvas A; Neromyliotis E; Koutsarnakis C; Komaitis S; Drosos E; Skandalakis GP; Pantazi M; Gobin YP; Stranjalis G; Patsalides A
    Neurosurg Rev; 2021 Apr; 44(2):773-792. PubMed ID: 32335853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Papilledema: are we any nearer to a consensus on pathogenesis and treatment?
    Lee AG; Wall M
    Curr Neurol Neurosci Rep; 2012 Jun; 12(3):334-9. PubMed ID: 22354546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update of idiopathic intracranial hypertension.
    Madriz Peralta G; Cestari DM
    Curr Opin Ophthalmol; 2018 Nov; 29(6):495-502. PubMed ID: 30169466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiopathic intracranial hypertension: ongoing clinical challenges and future prospects.
    Julayanont P; Karukote A; Ruthirago D; Panikkath D; Panikkath R
    J Pain Res; 2016; 9():87-99. PubMed ID: 26929666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endovascular treatment of idiopathic intracranial hypertension: retrospective analysis of immediate and long-term results in 51 patients.
    Aguilar-Pérez M; Martinez-Moreno R; Kurre W; Wendl C; Bäzner H; Ganslandt O; Unsöld R; Henkes H
    Neuroradiology; 2017 Mar; 59(3):277-287. PubMed ID: 28255904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Idiopathic intracranial hypertension is a serious condition in rapid growth].
    Yri HM; Jensen RH
    Ugeskr Laeger; 2012 Jun; 174(25):1737-40. PubMed ID: 22713222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic intracranial hypertension VISION (venous intervention versus shunting in IIH for optic nerve disc swelling) trial: patient perspective questionnaire.
    Chandran A; Pulhorn H; McMahon C
    Br J Neurosurg; 2019 Feb; 33(1):71-75. PubMed ID: 28934871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic Intracranial Hypertension: Implications for the Otolaryngologist.
    Pan DW; Vanstrum E; Doherty JK
    Otolaryngol Clin North Am; 2022 Jun; 55(3):579-594. PubMed ID: 35490040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transverse Sinus Stenting Reverses Medically Refractory Idiopathic Intracranial Hypertension.
    Reid K; Winters HS; Ang T; Parker GD; Halmagyi GM
    Front Ophthalmol (Lausanne); 2022; 2():885583. PubMed ID: 38983575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optical coherence tomography represents a sensitive and reliable tool for routine monitoring of idiopathic intracranial hypertension with and without papilledema.
    Huang-Link Y; Eleftheriou A; Yang G; Johansson JM; Apostolou A; Link H; Jin YP
    Eur J Neurol; 2019 May; 26(5):808-e57. PubMed ID: 30586220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of idiopathic intracranial hypertension].
    Wang YH; Ma J; Zhong Y
    Zhonghua Yan Ke Za Zhi; 2016 Dec; 52(12):948-951. PubMed ID: 27998460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic intracranial hypertension: mechanisms of visual loss and disease management.
    Wall M
    Semin Neurol; 2000; 20(1):89-95. PubMed ID: 10874779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous sinus stenting in idiopathic intracranial hypertension: a safer surgical approach?
    Chaudhry S; Bryant TK; Peeler CE
    Curr Opin Ophthalmol; 2016 Nov; 27(6):481-485. PubMed ID: 27585210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Endovascular treatment of idiopathic intracranial hypertension. Analysis of eight consecutive patients].
    Metellus P; Levrier O; Fuentes S; N'Doye N; Laghmari M; Adetchessi T; Dufour H; Donnet A; Conrath J; Grisoli F
    Neurochirurgie; 2007 Feb; 53(1):10-7. PubMed ID: 17336341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous sinus stenting shortens the duration of medical therapy for increased intracranial pressure secondary to venous sinus stenosis.
    Shazly TA; Jadhav AP; Aghaebrahim A; Ducruet AF; Jankowitz BT; Jovin TG; Bonhomme GR
    J Neurointerv Surg; 2018 Mar; 10(3):310-314. PubMed ID: 28487359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.